GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medivir AB (OTCPK:MVRBY) » Definitions » 3-Year EPS without NRI Growth Rate

Medivir AB (Medivir AB) 3-Year EPS without NRI Growth Rate : -7.30% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medivir AB 3-Year EPS without NRI Growth Rate?

Medivir AB's EPS without NRI for the three months ended in Mar. 2024 was $0.00.

During the past 3 years, the average EPS without NRI Growth Rate was -7.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 28.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Medivir AB was 118.50% per year. The lowest was -51.00% per year. And the median was 15.50% per year.


Competitive Comparison of Medivir AB's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Medivir AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medivir AB's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medivir AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Medivir AB's 3-Year EPS without NRI Growth Rate falls into.



Medivir AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Medivir AB  (OTCPK:MVRBY) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Medivir AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Medivir AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medivir AB (Medivir AB) Business Description

Industry
Traded in Other Exchanges
Address
Lunastigen 5, PO Box 1086, 2nd floor, Huddinge, SWE, 141 22
Medivir AB develops drugs with a focus on cancers where there are medical needs. The company invests in indication areas where available treatment methods are limited or lacking and there are opportunities to offer significant improvements to patients. Medivir focuses on the development of MIV-818, a prodrug that has been designed to provide a targeted anti-tumor effect in the liver while minimizing any side effects. Birinapant, a SMAC mimetic, has been out-licensed for development in combination with IGM antibodies for the treatment of solid tumors.